An Open-Label, Single Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profiles and Metabolite Identification of [14C]-Estetrol in Healthy Female Volunteers

Trial Profile

An Open-Label, Single Dose Study Designed to Assess the Mass Balance Recovery, Metabolite Profiles and Metabolite Identification of [14C]-Estetrol in Healthy Female Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 27 May 2016

At a glance

  • Drugs Estetrol (Primary)
  • Indications Atrophic vaginitis; Breast cancer; Migraine; Osteoarthritis; Vasomotor symptoms
  • Focus Pharmacokinetics
  • Sponsors Estetra S.A.
  • Most Recent Events

    • 17 May 2016 Status changed from recruiting to completed.
    • 29 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top